Eli Lilly VS Mochi Update from the Courtroom!
- Dave Knapp
- Sep 18, 2025
- 2 min read
Eli Lilly VS Mochi Update from the Courtroom!
Original posted at obesity.news/ on Aug 30, 2025
Today was a big day for our community. My friend Sabina, co-founder of GLPwinner.com, went inside the federal courthouse in San Francisco for the Eli Lilly vs Mochi Health hearing. Thanks to her efforts, we have the first patient-centered account of what actually went down. Without Sabina’s presence in the courtroom, we’d still be in the dark. I was honored to host her on On The Pen to spend some time chatting about not only what was discussed in the courtroom, but what this actually means for patients and the future of accessiblity to treatment. This is a topic that I know Sabina genuinely cares about deeply, and this conversation was a real treat… Enjoy:
Paid Subscribers are the lifeblood of OTP. While
hate to ask for anything of you, we simply
cannot do what we do without you. Your
support means everything to our efforts.
Sabina’s take on the hearing? “Embarassing” for Eli Lilly.
According to Sabina’s account, for nearly the entire 2 hour plus session, Judge Corley grilled Lilly’s counsel. Over and over she pressed them to produce concrete evidence and direct harms. The Judge Corley wasn’t satisfied with vague claims or hypotheticals. Screenshots of Reddit posts were about the strongest argument Lilly put forth, and that did not fly. She wanted facts, and Lilly simply did not deliver.
At one point she even said to Lilly’s lawyers: “What I hear you saying is that you don’t have anything.”
She challenged them on Article III standing, going claim by claim, asking what specific injury Lilly had suffered. At one point, she even told Lilly’s counsel if they didn’t like Mochi selling compounded medication, they should “go talk to the FDA and Congress.”
Judge Corley went on to question whether compounded patients were even Lilly’s customers to begin with. The judge contended that said patients likely couldn’t afford Lilly’s drugs, and without Mochi, they might have turned to other options altogether. When pressed on the actual price of Zepbound, Lilly’s counsel couldn’t provide the court with a clear answer.
According to Sabina’s account here are the main points that did not pass muster in the eye of Judge Corley:
Claims about Myra Ahmad allegedly presenting herself as a practicing medical doctor.
Arguments around Mochi shifting from Aequita pharmacy to others
Mochi marketing that referenced SURMOUNT trial results. The judge noted that in her estimation tirzepatide is tirzepatide.
Assertions that compounded versions are unsafe or ineffective, the burden of proof, she said, is on Lilly (which they were unable to substantiate).
The lack of specifics surrounding Aequita Pharmacy’s shutting down by the WA State Pharmacy Board.
Using Reddit as evidence without any meaningful follow up
We owe Sabina a debt of gratitude for this ground-level look at a fight that could shape the future of patient access. Please make sure to follow Sabina
on all the social feeds at @Lawliepop and @Lawliepops on instagram!
This blog explains salario diario integrado in a very simple and clear way. It highlights how salario diario integrado affects total compensation and benefits. The explanation is easy to follow. Understanding salario diario integrado helps employees verify their earnings and ensures employers maintain proper payroll practices today.
In Islam, Qurbani Ka Gosht is not only a blessing but also a responsibility that teaches us sharing and equality. It is recommended to divide Qurbani Ka Gosht into three parts: one for family, one for relatives and friends, and one for the needy. This practice spreads happiness and strengthens community bonds.
This is a really clear explanation of how We provide AI Solutions in Australia , helping businesses identify & implement intelligent AI solutions.
This courtroom breakdown is such an eye-opener — huge respect to Sabina for being there in person and giving the community a real, ground-level account! The fact that Judge Corley kept pushing Lilly for concrete evidence and they couldn't deliver beyond Reddit screenshots says everything. It's a bit like submitting an essay with no citations and hoping no one notices — it just doesn't hold up. What really stood out to me was the judge questioning whether compounded patients were even Lilly's customers to begin with, because affordability is the whole issue here. This situation honestly reminds me of an organizational leadership case study — a powerful company overestimating its influence and underestimating the court's expectations. For anyone trying to…
This courtroom breakdown is exactly what the community needed — thank you for sharing Sabina's firsthand account! It's honestly wild that Reddit screenshots were Lilly's strongest evidence, and Judge Corley's pushback on affordability really hit home. So many of us rely on compounded options precisely because branded Zepbound is financially out of reach, and it's validating to see a judge acknowledge that reality. The whole case feels like watching someone argue without doing their homework — and as someone who's used New Assignment Help UK for complex research tasks, I know firsthand that vague claims without solid evidence just don't hold up under scrutiny. The judge demanding concrete proof rather than hypotheticals gives me real hope that patient access will…